4//SEC Filing
Nantahala Capital Management, LLC 4
Accession 0001104659-25-057852
CIK 0001385818other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:31 PM ET
Size
9.9 KB
Accession
0001104659-25-057852
Insider Transaction Report
Form 4
Harkey Wilmot B.
10% Owner
Transactions
- Purchase
Prefunded Warrants
2025-06-06$1.50/sh+4,000,000$5,999,600→ 4,815,217 total(indirect: See footnote)Exercise: $0.00→ Common Stock (4,000,000 underlying)
Nantahala Capital Management, LLC
10% Owner
Transactions
- Purchase
Prefunded Warrants
2025-06-06$1.50/sh+4,000,000$5,999,600→ 4,815,217 total(indirect: See footnote)Exercise: $0.00→ Common Stock (4,000,000 underlying)
Mack Daniel
10% Owner
Transactions
- Purchase
Prefunded Warrants
2025-06-06$1.50/sh+4,000,000$5,999,600→ 4,815,217 total(indirect: See footnote)Exercise: $0.00→ Common Stock (4,000,000 underlying)
Footnotes (2)
- [F1]Subject to certain limits on beneficial ownership, the Prefunded Warrants may be exercised to purchase Issuer Common Stock at an exercise price of $0.0001 per share. The Prefunded Warrants do not expire until exercised in full.
- [F2]Nantahala Capital Management, LLC ("NCM"), an investment adviser to certain private funds and managed accounts (the "NCM Investors") that hold the Aytu BioPharma, Inc ("Issuer") securities disclosed in this Form 4, may be deemed a beneficial owner of such securities. Each of Mr. Wilmot B Harkey and Mr. Daniel Mack may be deemed a beneficial owner of Issuer securities beneficially owned by NCM. Each of NCM, Mr. Harkey and Mr. Mack disclaims beneficial ownership of the Issuer's securities disclosed herein except to the extent of their respective pecuniary interests therein.
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001472322
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:31 PM ET
- Size
- 9.9 KB